Teladoc Health, Inc. Common Stock (TDOC)
Healthcare › Services-Offices & Clinics of Doctors of Medicine
Price History
Feb 9, 2026 — May 24, 2026Investment Snapshot
- P/B of 0.89 — trading below book value
- Piotroski F-Score 5/9 — moderate financial health
- Loss-making — negative ROE of -17.9%
Teladoc Health, Inc. Common Stock (TDOC) is a Healthcare company operating in Services-Offices & Clinics of Doctors of Medicine, listed on the NYSE , with a market capitalisation of $1.2 billion . Key value metrics: P/B ratio 0.89, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Teladoc Health, Inc. Common Stock — Fundamental Analysis Summary
On financial health, TDOC shows a moderate Piotroski F-Score of 5/9, and negative return on equity of -17.9% (sector average: -20.6%), and elevated leverage with a debt-to-equity ratio of 1.06.
StockPik's composite Value Score for TDOC is 70/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
TDOC reports a high gross margin of 64.3% (sector average: 40.1%) and a negative operating margin of -11.5%.
TDOC shows revenue declining at 2% year-over-year, with earnings growing at 80%.